Journal of Clinical & Experimental Dermatology Research
Open Access

Hyperpigmentation disorders and update on skin lightening agents

16^th European Dermatology Congress

June 07-08, 2017 Milan, Italy

Marta I Rendon

Rendon Center for Dermatology and Aesthetic Medicine, USA

Posters & Accepted Abstracts: J Clin Exp Dermatol Res

Abstract :

Hyperpigmentation is a descriptive umbrella term for many skin conditions, which has both internal and external etiologies. Endogenous causes can include melasma, ochronosis, stasis dermatitis, and others, while exogenous causes encompass light exposure resulting in lentigines, drug-induced pigmentation, and post-inflammatory pigmentation secondary to any external cause such as acne, trauma, chemical peels, and laser therapy, amongst others. There are numerous treatment options ranging from topical, injectable, and systemic agents to medical devices. While certain treatment modalities are typically more successful than others, hyperpigmentation in general has traditionally been a challenging condition to treat. Benefits must always be weighed against their corresponding risks, and patient compliance with sun/light protection is paramount. Important factors to consider when treating these conditions will be discussed, including patient selection, genetic background, and prior treatment options. Post-inflammatory hyperpigmentation can occur after treatment with several of the available methods.

Biography :

Email: martarendon@yahoo.com